» Articles » PMID: 9422334

Peptidases in Human Bronchoalveolar Lining Fluid, Macrophages, and Epithelial Cells: Dipeptidyl (amino)peptidase IV, Aminopeptidase N, and Dipeptidyl (carboxy)peptidase (angiotensin-converting Enzyme)

Overview
Journal J Lab Clin Med
Publisher Elsevier
Date 1998 Jan 9
PMID 9422334
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The modulation of proteolytic activity is an important factor in regulating the metabolism and function of peptide hormones. In this study, the activities of dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme [ACE]), aminopeptidase N (APN), and dipeptidyl (amino)peptidase IV (DPP IV) were measured in the blood, the human bronchial epithelial and alveolar cells, bronchoalveolar macrophages, and the soluble phase of bronchoalveolar lavage (BAL) samples obtained from normal human volunteers and patients with pulmonary pathologic conditions. BAL fluid expressed ACE activity and very low levels of APN and DPP IV activities in the volunteer population, but higher levels could be measured in samples from patients. In patients, increased APN corresponded to a high granulocyte count, while DPP IV and ACE were associated with a high percentage of lymphocytes. Neither AIDS nor smoking induced an increased level of these enzymes. Immunohistochemical staining of bronchoalveolar smears with anti-human ACE monoclonal antibody showed that only macrophages expressed this enzyme. Enzyme histochemistry for DPP IV and APN showed that all leukocytes expressed these activities. APN, DPP IV, and ACE activities were also found in cell extracts of bronchoalveolar macrophages. In extracts of bronchial epithelial and alveolar cells, only APN and DPP IV activities were detected. Kinetic properties of the soluble enzymes in lavage supernatants were comparable to those of serum enzymes. These results demonstrate that soluble forms of cellular enzymes found in BAL fluid are regulated independently of blood and that different cell types may release these enzymes.

Citing Articles

Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions.

Padin J, Perez-Ortiz J, Redondo-Calvo F Int J Mol Sci. 2024; 25(13).

PMID: 39000315 PMC: 11241800. DOI: 10.3390/ijms25137209.


Development of the dipeptidyl peptidase 4 family and its association with lung diseases: a narrative review.

Hua E, Xu D, Chen H, Zhang S, Feng J, Xu L J Thorac Dis. 2024; 15(12):7024-7034.

PMID: 38249892 PMC: 10797411. DOI: 10.21037/jtd-23-1158.


Functional Roles for CD26/DPP4 in Mediating Inflammatory Responses of Pulmonary Vascular Endothelial Cells.

Takahashi Y, Kawasaki T, Sato H, Hasegawa Y, Dudek S, Ohara O Cells. 2021; 10(12).

PMID: 34944016 PMC: 8700481. DOI: 10.3390/cells10123508.


In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses.

Fard S, Petrone L, Petruccioli E, Alonzi T, Matusali G, Colavita F Biomed Res Int. 2021; 2021:8856018.

PMID: 34239932 PMC: 8221881. DOI: 10.1155/2021/8856018.


Development of new in vitro models of lung protease activity for investigating stability of inhaled biological therapies and drug delivery systems.

Woods A, Andrian T, Sharp G, Bicer E, Vandera K, Patel A Eur J Pharm Biopharm. 2019; 146:64-72.

PMID: 31756380 PMC: 6963770. DOI: 10.1016/j.ejpb.2019.11.005.


References
1.
Kenny A, OHare M, Gusterson B . Cell-surface peptidases as modulators of growth and differentiation. Lancet. 1989; 2(8666):785-7. DOI: 10.1016/s0140-6736(89)90841-6. View

2.
Specks U, Martin 2nd W, Rohrbach M . Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases. Am Rev Respir Dis. 1990; 141(1):117-23. DOI: 10.1164/ajrccm/141.1.117. View

3.
Luisetti M, Piccioni P, Donnetta A, Bulgheroni A, Peona V . Protease-antiprotease imbalance: local evaluation with bronchoalveolar lavage. Respiration. 1992; 59 Suppl 1:24-7. DOI: 10.1159/000196099. View

4.
Juillerat L, Nussberger J, Menard J, Mooser V, Christen Y, Waeber B . Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension. 1990; 16(5):564-72. DOI: 10.1161/01.hyp.16.5.564. View

5.
Proud D, Subauste M, Ward P . Glucocorticoids do not alter peptidase expression on a human bronchial epithelial cell line. Am J Respir Cell Mol Biol. 1994; 11(1):57-65. DOI: 10.1165/ajrcmb.11.1.7517143. View